HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Kent E Wallner Selected Research

Brachytherapy

9/2015Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials.
12/2013Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatment.
9/2013Long-term outcomes of prostate cancer patients with Gleason pattern 5 treated with combined brachytherapy and external beam radiotherapy.
5/2013Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy".
1/2013Gleason score 7 prostate cancer treated with interstitial brachytherapy with or without supplemental external beam radiation and androgen deprivation therapy: is the primary pattern on needle biopsy prognostic?
12/2012The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
9/2012Patient-reported long-term rectal function after permanent interstitial brachytherapy for clinically localized prostate cancer.
7/2012Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy.
2/2012Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer.
1/2012Serum testosterone kinetics after brachytherapy for clinically localized prostate cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Kent E Wallner Research Topics

Disease

69Prostatic Neoplasms (Prostate Cancer)
09/2015 - 10/2002
20Neoplasms (Cancer)
09/2013 - 10/2002
10Hypertension (High Blood Pressure)
11/2009 - 06/2003
5Adenocarcinoma
01/2005 - 10/2002
4Neoplasm Metastasis (Metastasis)
12/2013 - 10/2008
4Erectile Dysfunction
01/2012 - 01/2003
4Carcinoma (Carcinomatosis)
07/2010 - 05/2003
4Dysuria
10/2007 - 03/2003
3Diabetes Mellitus
12/2012 - 01/2003
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2006 - 08/2004
2Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 09/2006
2Obesity
07/2011 - 12/2007
2Urethral Stricture
04/2006 - 07/2005
1Cardiovascular Diseases (Cardiovascular Disease)
01/2010
1Overactive Urinary Bladder (Overactive Bladder)
03/2008
1Myocardial Infarction
10/2006
1Rectal Neoplasms (Rectal Cancer)
09/2006
1Polyps
09/2006
1Pathologic Constriction (Stenosis)
04/2006
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2003
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2003
1Hypertrophy
01/2003
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2003

Drug/Important Bio-Agent (IBA)

13Prostate-Specific Antigen (Semenogelase)IBA
07/2012 - 01/2003
10HormonesIBA
08/2010 - 10/2002
3Testosterone (Sustanon)FDA Link
01/2012 - 07/2009
2atorvastatin (Lipitor)FDA Link
08/2006 - 12/2005
2sildenafil (Viagra)FDA Link
05/2003 - 01/2003
1thiaclopridIBA
06/2010
1trospium chloride (Ceris)FDA LinkGeneric
03/2008
1bicalutamide (Casodex)FDA LinkGeneric
07/2006
1dutasteride (Avodart)FDA Link
07/2006
1prostatic acid phosphataseIBA
05/2005
1tamsulosin (Flomax)FDA LinkGeneric
03/2005
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2004

Therapy/Procedure

75Brachytherapy
09/2015 - 10/2002
14Radiotherapy
09/2015 - 10/2002
4Catheters
10/2007 - 08/2004
3Prostatectomy (Retropubic Prostatectomy)
02/2012 - 08/2008
2Aftercare (After-Treatment)
12/2013 - 09/2006
2Transurethral Resection of Prostate (TURP)
07/2005 - 01/2004
1Colostomy
09/2012
1Drug Therapy (Chemotherapy)
08/2008